Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension

被引:118
|
作者
Cerasola, G
Cottone, S
Mule, G
Nardi, E
Mangano, MT
Andronico, G
Contorno, A
LiVecchi, M
Galione, P
Renda, F
Piazza, G
Volpe, V
Lisi, A
Ferrara, L
Panepinto, N
Riccobene, R
机构
[1] UNIV PALERMO,CHAIR INTERNAL MED,PALERMO,ITALY
[2] UNIV PALERMO,DIV CLIN PATHOPHYSIOL & HYPERTENS,PALERMO,ITALY
关键词
microalbuminuria; left ventricular hypertrophy; hypertensive nephropathy; hypertensive retinopathy; target organ damage;
D O I
10.1097/00004872-199607000-00016
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective To evaluate the prevalence of microalbuminuria (albumin excretion rate, AER) in a wide hypertensive population, and to evaluate any relationship with cardiovascular damage and renal dysfunction. Design A transversal study. Subjects and methods In 383 hospitalized Caucasian essential hypertensives (198 men, 185 women) of mean age 44 +/- 0.5 years and mean clinic blood pressure 170.3 +/- 0.95/103.4 +/- 0.47 mmHg, metabolic parameters, serum creatinine level (C-S), creatinine clearance rate (C-CR), 24 AER and plasma renin activity (PRA) were measured. Furthermore, each patient underwent 24 h ambulatory blood pressure monitoring (ABPM) and echocardiography to measure left ventricular mass, which was indexed both by body surface area to obtain left ventricular mass index (LVMI) and by height to obtain the left ventricular mass indexed for height (LVMH). By Doppler echocardiography, the diastolic compliance by early:late peak filling velocity ratio was analysed. The fundus oculi was also observed. Three subsets of hypertensives were obtained by dividing the 383 essential hypertensives on the basis of their AER: less than or equal to 11 (group A), 11 less than or equal to 20 (group B) and > 20 mu g/min (group C). Main outcome measures Microalbuminuria, creatinine clearance, PRA, ABPM, LVMI, LVMH, early:late peak filling velocity ratio, hypertensive retinopathy. Results Among the 383 essential hypertensives, AER was <11 mu g/min in 55% of the patients (group A), 18% had AER in the range 11-20 mu g/min (group B) and 27% had AER >20 mu g/min (group C). In the entire essential hypertensive population the prevalence of left ventricular hypertrophy was 44.39% and hypertensive retinopathy was observed in 54.83%. Moreover, AER significantly correlated with clinic systolic blood pressure (SEP) and diastolic blood pressure (DBP), with 24 SBP and DBP and with 24 h daytime and night-time mean blood pressure (MBP). AER was correlated also with LVMH and creatinine clearance. The analysis of the three subsets revealed no differences in age, body mass index, serum creatinine level and PRA. Group C in comparison with group A showed higher values of clinic SEP, 24 h SBP, DBP and MBP, and of daytime and nighttime MBP. Furthermore, in group C, LVMI and LVMH were significantly greater than in group A, with a prevalence of left ventricular hypertrophy of 55% in the former group. Group C showed a prevalence of hypertensive retinopathy of 69% whereas in group A the prevalence was 48%. In group C, AER was significantly correlated with serum creatinine level. Conclusion The transversal phase of our research, performed in a homogeneous population of Caucasian essential hypertensives with no metabolic disturbances, confirms the relationship between blood pressure pattern and early glomerular changes in essential hypertensives without overt proteinuria. Furthermore, these results emphasize the role of microalbuminuria as a marker of early cardiac, renal and retinal structural and functional changes in essential hypertension. The longitudinal study, which is in progress, will confirm the prognostic value of microalbuminuria in essential hypertension.
引用
收藏
页码:915 / 920
页数:6
相关论文
共 50 条
  • [1] Microalbuminuria and essential hypertension: renal and cardiovascular implications
    Luft, FC
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1997, 6 (06): : 553 - 557
  • [2] Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension?
    Campese, VM
    Bianchi, S
    Bigazzi, R
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2000, 9 (02): : 143 - 147
  • [3] Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension
    Bigazzi, R
    Bianchi, S
    Baldari, D
    Campese, VM
    JOURNAL OF HYPERTENSION, 1998, 16 (09) : 1325 - 1333
  • [4] MICROALBUMINURIA AS A MARKER OF CARDIOVASCULAR AND RENAL-DISEASE IN ESSENTIAL-HYPERTENSION
    BIGAZZI, R
    BIANCHI, S
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 : 10 - 14
  • [5] Is microalbuminuria (mu A) a predictor of cardiovascular and renal events in essential hypertension (EH)?.
    Bianchi, S
    Bigazzi, R
    Baldari, G
    Campese, VM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1442 - A1442
  • [6] Hypertension, microalbuminuria and renal dysfunction: the Renal Dysfunction in Hypertension (REDHY) study
    Cerasola, Giovanni
    Mule, Giuseppe
    Cottone, Santina
    Nardi, Emilio
    Cusimanol, Paola
    JOURNAL OF NEPHROLOGY, 2008, 21 (03) : 368 - 373
  • [7] Microalbuminuria and renal haemodynamics in essential hypertension
    Mattei, P
    Arzilli, F
    Giovannetti, R
    Penno, G
    Arrighi, P
    Taddei, S
    Salvetti, A
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (09) : 755 - 760
  • [8] MICROALBUMINURIA AND ENDOTHELIAL DYSFUNCTION IN ESSENTIAL-HYPERTENSION
    PEDRINELLI, R
    GIAMPIETRO, O
    CARMASSI, F
    MELILLO, E
    DELLOMO, G
    CATAPANO, G
    MATTEUCCI, E
    TALARICO, L
    MORALE, M
    DENEGRI, F
    DIBELLO, V
    LANCET, 1994, 344 (8914): : 14 - 18
  • [9] Microalbuminuria, cardiovascular, and renal risk in primary hypertension
    Pontremoli, R
    Leoncini, G
    Ravera, M
    Viazzi, F
    Vettoretti, S
    Ratto, E
    Parodi, D
    Tomolillo, C
    Deferrari, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (11): : S169 - S172
  • [10] MICROALBUMINURIA AS A PREDICTOR OF CARDIOVASCULAR DAMAGE IN ESSENTIAL-HYPERTENSION
    CERASOLA, G
    COTTONE, S
    DIGNOTO, G
    GRASSO, L
    MANGANO, MT
    CARAPELLE, E
    NARDI, E
    ANDRONICO, G
    FULANTELLI, MA
    MARCELLINO, T
    SEDDIO, G
    JOURNAL OF HYPERTENSION, VOL 7, SUPPL 6: PROCEEDINGS OF THE FOURTH EUROPEAN MEETING ON HYPERTENSION, 1989, : S332 - S333